Stay updated on Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Sign up to get notified when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.

Latest updates to the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page
- Check2 days agoChange DetectedThe page now shows a minor revision update: Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now shows revision v3.4.1 and removed v3.4.0. This update affects only the version annotation and not the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe update is a minor site revision tag changed from v3.3.3 to v3.3.4 at the bottom of the page; no trial content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded a Locations section with Henan (Zhengzhou, Henan, China) and related location details. Removed the Henan Locations entry and the HHS Vulnerability Disclosure link, and updated the revision tag to v3.3.3.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0. No substantive changes to the study details or page content are evident.SummaryDifference0.1%

- Check90 days agoChange DetectedRemoved the government funding status notice that warned information might not be up to date due to appropriations, which previously informed users about potential delays or unresponsiveness of the NIH Clinical Center. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.